István Gábor Takács is a human rights activist, videographer and trainer. He ran the Video Advocacy Program of the Hungarian Civil Liberties Union between 2007-2015. He worked as a needle exchange program counselor for 5 years. He is author of several articles on harm reduction and cameraman, editor, director and co-director of more than 700 online videos, among them longer documentaries, such as “Kostya Proletarsky” (2020), “Taking Back What’s Ours: An Oral History of the Movement of People who Use Drugs” (2020) ”A Day in the Life: The World of Humans Who Use Drugs” (2016), “Without Rights” (2009), “Without a Chance” (2014), “Room in the 8th District” (2014) and “The Invisible” (2011). Since 2016 he works at the Rights Reporter Foundation, where besides producing films, he is training activists in video advocacy.
What happens after a psychedelic experience? In this Drug Reporter Café interview, coach and educator Márton Mányai explores how integration coaching can help people make sense of their experiences and bring insights into everyday life.
Can psychedelic-assisted therapy help people heal from trauma while also repairing their closest relationships? At ICPR 2026, we sat down with clinical psychologist Anne Wagner, founder of the Remedy Institute, to discuss her pioneering research on MDMA-assisted therapy for PTSD and couples therapy, the role of connection in recovery, and the future of trauma treatment.
In September 2026, the Norwegian government announced that heroin-assisted treatment now becomes a permanent treatment option in the country. Join us on a visit to Bergen’s HABIB, one of the pilot heroin-assisted treatment programs, to learn how heroin-assisted treatment works in practice!
What happens when an altered state of consciousness becomes part of psychotherapy? We visited a new clinic in Vienna offering ketamine-assisted therapy. Dr. Claus Derganc showed us around and discussed the treatment’s potential, its risks, and how patients work through difficult experiences.
At ICPR 2024, we talked to Jamila Hokanson,from the Yale University School of Medicine, about how psychedelics might offer new hope for people living with obsessive-compulsive disorder (OCD).
At ICPR 2024, we talked to Leonie Schneider and Ian Roullier, co-founders and co-directors of the Psychedelic Participant Advocacy Network (PsyPAN) in the UK, about why patient voices matter in the development of psychedelic therapy.
What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researcher Sandeep Nayak about clinical trials, common therapeutic factors, and how the field can better understand the mechanisms behind psychedelic-assisted treatment.
At ICPR 2024, we talked to Robert Jesse, from the Johns Hopkins University, about mystical experiences with psychedelics, their spiritual and cultural dimensions, and the value of community in supporting their responsible integration.
At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce compulsive thinking and support addiction treatment.
What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researcher Sandeep Nayak about clinical trials, common therapeutic factors, and how the field can better understand the mechanisms behind psychedelic-assisted treatment.
